Matsuo N - Search Results

1

Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less.

Okamoto M, Fujimoto K, Chikasue T, Yanagihara T, Tabata K, Zaizen Y, Tominaga M, Sumi A, Takeoka H, Matsuo N, Nouno T, Kawaguchi A, Hoshino T. Okamoto M, et al. Among authors: matsuo n. Respir Investig. 2024 Dec 16;63(1):109-117. doi: 10.1016/j.resinv.2024.12.005. Online ahead of print. Respir Investig. 2024. PMID: 39689588

2

Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias.

Koga T, Okamoto M, Satoh M, Fujimoto K, Zaizen Y, Chikasue T, Sumi A, Kaieda S, Matsuo N, Matama G, Nouno T, Tominaga M, Yatera K, Ida H, Hoshino T. Koga T, et al. Among authors: matsuo n. Biomedicines. 2022 Oct 2;10(10):2469. doi: 10.3390/biomedicines10102469. Biomedicines. 2022. PMID: 36289730 Free PMC article.

3

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

Murata D, Azuma K, Matama G, Zaizen Y, Matsuo N, Murotani K, Tokito T, Hoshino T. Murata D, et al. Among authors: matsuo n. Thorac Cancer. 2023 Jan;14(1):73-80. doi: 10.1111/1759-7714.14718. Epub 2022 Nov 14. Thorac Cancer. 2023. PMID: 36377039 Free PMC article.

4

Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Matama G, Okamoto M, Fujimoto K, Johkoh T, Tominaga M, Mukae H, Sakamoto N, Komiya K, Umeki K, Komatsu M, Shimizu Y, Takahashi K, Tokisawa S, Zaizen Y, Matsuo N, Nouno T, Kaieda S, Ida H, Izuhara K, Hoshino T. Matama G, et al. Among authors: matsuo n. J Clin Med. 2023 Nov 15;12(22):7100. doi: 10.3390/jcm12227100. J Clin Med. 2023. PMID: 38002712 Free PMC article.

5

Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine.

Tanaka T, Okamoto M, Matsuo N, Naitou-Nishida Y, Nouno T, Kojima T, Nishii Y, Uchiyashiki Y, Takeoka H, Nagasaki Y. Tanaka T, et al. Among authors: matsuo n. Medicina (Kaunas). 2023 Mar 10;59(3):541. doi: 10.3390/medicina59030541. Medicina (Kaunas). 2023. PMID: 36984543 Free PMC article.

6

Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy.

Ishii H, Azuma K, Yamada K, Matsuo N, Nakamura M, Tokito T, Kinoshita T, Hoshino T. Ishii H, et al. Among authors: matsuo n. BMJ Open Respir Res. 2017 Jan 10;4(1):e000163. doi: 10.1136/bmjresp-2016-000163. eCollection 2017. BMJ Open Respir Res. 2017. PMID: 28123750 Free PMC article.

7

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients.

Takeoka H, Yamada K, Naito Y, Matsuo N, Ishii H, Tokito T, Azuma K, Ichiki M, Hoshino T. Takeoka H, et al. Among authors: matsuo n. Anticancer Res. 2018 Jun;38(6):3779-3784. doi: 10.21873/anticanres.12661. Anticancer Res. 2018. PMID: 29848743 Clinical Trial.

8

Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

Murata D, Azuma K, Murotani K, Matsuo N, Matama G, Tokito T, Sasada T, Hoshino T. Murata D, et al. Among authors: matsuo n. Lung Cancer. 2023 Oct;184:107351. doi: 10.1016/j.lungcan.2023.107351. Epub 2023 Aug 20. Lung Cancer. 2023. PMID: 37639819

9

Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexed.

Matama G, Tokito T, Takeoka H, Hiraoka Y, Matsuo N, Nakamura M, Ishii H, Kinoshita T, Azuma K, Yamada K, Hoshino T. Matama G, et al. Among authors: matsuo n. Invest New Drugs. 2017 Oct;35(5):662-664. doi: 10.1007/s10637-017-0462-z. Epub 2017 Mar 30. Invest New Drugs. 2017. PMID: 28361276

10

Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.

Matsuo N, Azuma K, Kojima T, Ishii H, Tokito T, Yamada K, Hoshino T. Matsuo N, et al. Invest New Drugs. 2021 Aug;39(4):1150-1158. doi: 10.1007/s10637-021-01069-7. Epub 2021 Jan 22. Invest New Drugs. 2021. PMID: 33483882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

907 results

Search Page

Filters